Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2265382
Reference Type
Journal Article
Subtype
Abstract
Title
Nasal nitric oxide & ciliary function in patients with non-heterotaxy congenital heart disease
Author(s)
Kureshi, S; Nakhleh, N; Setton, M; Giese, R; Francis, R; Chatterjee, B; Sami, I; Kuehl, K; Olivier, KN; Jonas, R; Tian, X; Leigh, MW; Knowles, MR; Leatherbury, L; Lo, C
Year
2010
Is Peer Reviewed?
Yes
Journal
American Journal of Respiratory and Critical Care Medicine
ISSN:
1073-449X
EISSN:
1535-4970
Volume
181
Page Numbers
A3323
Language
English
DOI
10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A3323
Web of Science Id
WOS:000208771002434
Relationship(s)
is part of a larger document
3452678
Proceedings of the American Thoracic Society 2010 International Conference, May 14-19, 2010, New Orleans
Abstract
RATIONALE: Heterotaxy is a rare disorder characterized by discordant abdominal/thoracic organ situs due to aberrant left-right patterning, a developmental process dependent on motile cilia in the embryonic node. Ciliary dysfunction is implicated in complex congenital heart disease (CHD) associated with heterotaxy. We previously found 40% incidence of CHD associated with heterotaxy in a murine model of primary ciliary dyskinesia (PCD). In a study of 45 patients with CHD associated with heterotaxy, we observed 42% incidence of ciliary dysfunction defined by nasal nitric oxide (nNO) level that is low (<100 nl/min for ≥6 years or <50 nl/min for 1-6 years) or borderline low (< 2 standard deviations below the mean) and abnormal ciliary motion as observed by videomicroscopy. We refer to this as vCD (variant ciliary dysfunction). Significantly, patients with vCD have more chronic respiratory symptoms, suggesting the possibility that diminished mucociliary clearance may contribute to increased respiratory complications and higher postsurgical morbidity of heterotaxy patients.
METHODS AND RESULTS: To examine whether vCD may have broader relevance to CHD, we expanded our study to include CHD patients without heterotaxy. As in our previous study, nNO was measured utilizing a chemiluminescence nNO analyzer, and we also performed nasal biopsy and conducted ciliary motion analysis of the respiratory epithelia using high-speed videomicroscopy. Of 5 non-heterotaxy CHD patients examined ranging from 2 months to 19 years old, one 17-year old male with double chambered right ventricle and ventricular septal defect exhibited vCD. His nNO was 142 nl/min and his nasal biopsy showed asynchronous ciliary motion with incomplete stroke. With the ready availability of CHD patients, we expect to recruit many more CHD patients in the coming months to assess the prevalence of vCD in CHD patients without heterotaxy.
CONCLUSION: Ciliary dysfunction was previously shown to be closely linked to CHD associated with heterotaxy. Preliminary findings suggest ciliary dysfunction may also have a role to play in CHD without heterotaxy, a possibility we will further evaluate in our ongoing studies.
Conference Name
American Thoracic Society 2010 International Conference
Conference Location
New Orleans, LA
Conference Dates
May 14-19, 2010
Tags
•
LitSearch-NOx (2024)
Keyword Search
Epidemiology
March 2014-November 2016
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity